ChiCTR2600120324 版本V1.0 版本创建时间2026/03/12 10:34:34 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600120324 

最近更新日期:

Date of Last Refreshed on:

2026-03-12 10:34:28 

注册时间:

Date of Registration:

2026-03-12 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

体外冲击波治疗帕金森病患者小腿三头肌肌强直的疗效研究

Public title:

Study on the Efficacy of Extracorporeal Shock Wave Therapy for Triceps Surae Muscle Spasticity in Patients with Parkinson's Disease

注册题目简写:

English Acronym:

研究课题的正式科学名称:

体外冲击波治疗帕金森病患者小腿三头肌肌强直的疗效研究

Scientific title:

Study on the Efficacy of Extracorporeal Shock Wave Therapy for Triceps Surae Muscle Spasticity in Patients with Parkinson's Disease

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

许光旭 

研究负责人:

许光旭 

Applicant:

Xu Guangxu 

Study leader:

Xu Guangxu 

申请注册联系人电话:

Applicant telephone:

+86 139 5173 1331

研究负责人电话:

Study leader's
telephone:

+86 139 5173 1331

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

xuguangxu1@126.com

研究负责人电子邮件:

Study leader's E-mail:

xuguangxu1@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

中国江苏省南京市鼓楼区广州路300号

研究负责人通讯地址:

中国江苏省南京市鼓楼区广州路300号

Applicant address:

No. 300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China

Study leader's address:

No. 300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

南京医科大学第一附属医院(江苏省人民医院)

Applicant's institution:

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

研究负责人所在单位:

南京医科大学第一附属医院(江苏省人民医院)

Affiliation of the Leader:

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2024-SR-733

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南京医科大学第一附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of the First Affiliated Hospital of Nanjing Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2024-10-08 00:00:00

伦理委员会联系人:

赵俊

Contact Name of the ethic committee:

Zhao Jun

伦理委员会联系地址:

中国江苏省南京市鼓楼区广州路300号

Contact Address of the ethic committee:

No. 300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 25 6830 6360

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南京医科大学第一附属医院(江苏省人民医院)

Primary sponsor:

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

研究实施负责(组长)单位地址:

中国江苏省南京市鼓楼区广州路300号

Primary sponsor's address:

No. 300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏

市(区县):

Country:

China

Province:

Jiangsu

City:

单位(医院):

南京医科大学第一附属医院(江苏省人民医院)

具体地址:

中国江苏省南京市鼓楼区广州路300号

Institution
hospital:

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

Address:

No. 300, Guangzhou Road, Gulou District, Nanjing, Jiangsu, China

经费或物资来源:

Source(s) of funding:

N/A

研究疾病:

帕金森病  

Target disease:

Parkinson's disease

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1.开展临床RCT研究,严格验证体外冲击波治疗(Extracorporeal shock wave therapy,ESWT)作用于小腿三头肌对于下肢运动肌强直缓解的疗效,为其临床转化提供循证医学证据; 2.突破ESWT作用于小腿三头肌用于改善肌强直症状的研究空白,为临床上缓解肌强直方案提供新思路; 3.对比分析ESWT作用于小腿三头肌缓解肌强直症状的有效性,完善ESWT的探头选择、频率、强度等。  

Objectives of Study:

1. Conduct clinical RCT studies to rigorously verify the efficacy of extracorporeal shock wave therapy (ESWT) on the triceps surae in alleviating lower limb spasticity, providing evidence-based medical support for its clinical translation; 2. Break new ground in research on using ESWT on the triceps surae to improve spasticity symptoms, offering new ideas for clinical spasticity management strategies; 3. Compare and analyze the effectiveness of ESWT on the triceps surae in relieving spasticity symptoms, and refine parameters such as probe selection, frequency, and intensity.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)年龄范围18-80岁; (2)诊断符合《中国帕金森病的诊断标准(2016版)》; (3)神志清楚、生命体征稳定的患者; (4)小腿三头肌痉挛,1级≤MAS分级≤3级; (5)经MMSE量表评定大于等于20分,认知能配合试验;

Inclusion criteria

(1) Age range: 18 - 80 years old; (2) Diagnosis conforms to the "Diagnostic Criteria for Parkinson's Disease in China (2016 Edition)"; (3) Clear consciousness, stable vital signs of the patient; (4) Triceps surae spasticity, 1st grade <= MAS grade <= 3rd grade; (5) MMSE assessment score is greater than or equal to 20 points, and cognitive function can cooperate with the test;

排除标准:

(1)有认知障碍、精神障碍的患者; (2)有体外冲击波禁忌症患者(严重凝血功能障碍,治疗区域存在恶性肿瘤); (3)心、肝、肾、脑功能衰竭等严重合并症的患者; (4)近3个月有下肢手术、踝关节挛缩、严重关节炎等病史者或局部感染及皮肤破溃者; (5)服用抗痉挛药物、局部注射肉毒杆菌毒素、苯酚或酒精等; (6)进行性或者严重的神经系统疾病。

Exclusion criteria:

(1) Patients with cognitive or mental disorders; (2) Patients with contraindications for extracorporeal shock wave therapy (severe coagulation disorders, presence of malignant tumors in the treatment area); (3) Patients with severe comorbidities such as heart, liver, kidney, or brain failure; (4) Patients with a history of lower limb surgery, ankle joint contracture, severe arthritis in the past 3 months, or with local infections or skin lesions; (5) Patients taking antispasmodic medications or receiving local injections of botulinum toxin, phenol, or alcohol; (6) Patients with progressive or severe neurological diseases.

研究实施时间:

Study execute time:

From 2024-10-10 00:00:00 To 2026-01-20 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-10-10 00:00:00 To 2026-01-20 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

22

Group:

Experimental group

Sample size:

干预措施:

体外冲击波

干预措施代码:

Intervention:

Extracorporeal shock wave

Intervention code:

组别:

对照组

样本量:

22

Group:

Control group

Sample size:

干预措施:

假刺激

干预措施代码:

Intervention:

Pseudo-stimulation

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏 

市(区县):

 

Country:

China

Province:

Jiangsu

City:

单位(医院):

南京医科大学第一附属医院(江苏省人民医院) 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

下肢运动功能

指标类型:

主要指标

Outcome:

Lower Limb Motor Function

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

表面肌电图

指标类型:

主要指标

Outcome:

Surface Electromyography, sEMG

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

改良Ashworth量表

指标类型:

主要指标

Outcome:

Modified Ashworth Scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

视觉模拟量表

指标类型:

主要指标

Outcome:

Visual Analog Scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

功能独立性水平

指标类型:

主要指标

Outcome:

Functional Independence Level

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字法

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2026-06-20;2781994043@qq.com

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

2027-03-01; 2781994043@qq.com

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据由量表及病例采集,由医院电子采集系统管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The data is collected through scales and case records and managed by the hospital's electronic collection system.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-03-12 10:34:28